Financials data is unavailable for this security.
View more
Year on year STRATA Skin Sciences Inc 's revenues fell -7.75% from 36.16m to 33.36m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 5.55m to a larger loss of 10.83m.
Gross margin | 54.30% |
---|---|
Net profit margin | -25.40% |
Operating margin | -22.70% |
Return on assets | -17.54% |
---|---|
Return on equity | -62.97% |
Return on investment | -24.26% |
More ▼
Cash flow in USDView more
In 2023, STRATA Skin Sciences Inc increased its cash reserves by 19.47%, or 1.32m. Cash Flow from Financing totalled 6.86m or 20.57% of revenues. In addition the company used 519.00k for operations while cash used for investing totalled 5.02m.
Cash flow per share | -0.8682 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.71 |
---|---|
Tangible book value per share | -0.9575 |
More ▼
Balance sheet in USDView more
Current ratio | 1.14 |
---|---|
Quick ratio | 0.9176 |
Total debt/total equity | 1.59 |
---|---|
Total debt/total capital | 0.6141 |
More ▼